We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

18 hedge funds and large institutions have $1.93M invested in Plus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

29% more funds holding

Funds holding: 14 → 18 (+4)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more ownership

Funds ownership: 0.04% → 0.04% (+0%)

41% less capital invested

Capital invested by funds: $3.26M → $1.93M (-$1.32M)

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OCA
Otter Creek Advisors
Florida
+$164K
2
GVAG
Great Valley Advisor Group
Delaware
+$22.5K
3
Renaissance Technologies
Renaissance Technologies
New York
+$22.5K
4
WAM
Warberg Asset Management
Illinois
+$16.7K
5
Millennium Management
Millennium Management
New York
+$14.2K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$28.2K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$19.7K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$11K
4
Osaic Holdings
Osaic Holdings
Arizona
-$5.74K
5
Morgan Stanley
Morgan Stanley
New York
-$2.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
PHP
1
Parkman Healthcare Partners
Connecticut
$828K +$4.5K +18 +0.4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$462K – – –
OCA
3
Otter Creek Advisors
Florida
$178K +$164K +656 +293%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$139K – – –
Morgan Stanley
5
Morgan Stanley
New York
$64K -$2.5K -10 -3%
BlackRock
6
BlackRock
New York
$56K -$28.2K -113 -29%
Renaissance Technologies
7
Renaissance Technologies
New York
$55K +$22.5K +90 +50%
Two Sigma Advisers
8
Two Sigma Advisers
New York
$27K -$19.7K -79 -37%
State Street
9
State Street
Massachusetts
$19K – – –
Creative Planning
10
Creative Planning
Kansas
$18K +$8.24K +33 +59%
GVAG
11
Great Valley Advisor Group
Delaware
$18K +$22.5K +90 New
Northern Trust
12
Northern Trust
Illinois
$17K – – –
WAM
13
Warberg Asset Management
Illinois
$14K +$16.7K +67 New
Millennium Management
14
Millennium Management
New York
$12K +$14.2K +57 New
TRCT
15
Tower Research Capital (TRC)
New York
$11K +$7.24K +29 +116%
UBS Group
16
UBS Group
Switzerland
$7K +$9.24K +37 New
ATPW
17
Ashton Thomas Private Wealth
Arizona
$6.61K +$8.24K +33 New
Osaic Holdings
18
Osaic Holdings
Arizona
$1K -$5.74K -23 -82%
FP
19
Financial Perspectives
Minnesota
$1 – – –
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
– -$11K -29 Closed

PSTV Hedge Fund Activity: Q2 2022 in Review

18 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2022, worth a combined $1.93M — down 41% from $3.26M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PSTV positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Otter Creek Advisors, adding an estimated $164K. The largest seller was BlackRock, cutting an estimated $28.2K.

  • 18 institutional investors held Plus Therapeutics (PSTV) as of Q2 2022, up from 14 in Q1 2022.
  • Funds reported $1.93M of Plus Therapeutics stock for Q2 2022, down 41% quarter-over-quarter.
  • 5 funds opened new Plus Therapeutics positions in Q2 2022 and 1 closed out, a net change of +4 holders.
  • The largest Plus Therapeutics buyer in Q2 2022 was Otter Creek Advisors, an estimated $164K added.
  • The largest Plus Therapeutics seller in Q2 2022 was BlackRock, an estimated $28.2K sold.

Based on aggregated 13F filings for Q2 2022.